ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today that its MalaCards database has been recognized in a published paper by the Weizmann Institute of Science research group under the supervision of Prof. Doron Lancet from the Department of Molecular Genetics, in collaboration with LifeMap Sciences. MalaCards (available as of Oct 2012 via www.malacards.org), is a database of human diseases and their annotations that is modeled on the architecture and richness of the popular GeneCards® database of human genes (available at www.genecards.org). LifeMap Sciences holds the exclusive worldwide license to market GeneCards® and MalaCards, from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science.
